INS and metabolic dysfunction-associated steatotic liver disease: p = 0.032) but not BMI, fasting insulin, HOMA-IR, liver enzymes (ALT, AST, GGT), NAFLD liver fat score [23], triglyceride levels assessed in liver samples, and serum cytokines (IL6, TNF alpha, MCP1).